Growing Hospital Adoption Velano Vascular's PIVO technology is already adopted by many top hospital systems across the nation, including Intermountain Healthcare and Sutter Health, indicating strong institutional interest and a proven track record of integration within clinical workflows which presents a significant opportunity for expanding sales within large healthcare networks.

Awarded Innovation Leadership Recognition as one of Fast Company's Most Innovative Companies and receiving the Frost & Sullivan Product Leadership Award highlight the company's innovation edge, positioning it as a forward-thinking partner that can meet the evolving needs of healthcare providers seeking cutting-edge solutions for patient comfort and safety.

Funding and Growth Potential With $25 million in growth financing secured and recent investments from notable entities like Intermountain Healthcare, Velano Vascular demonstrates financial backing and market validation, making it a promising candidate for further commercialization efforts and strategic partnerships in hospital markets.

Innovation in Blood Collection PIVO's needle-free blood draw technology addresses key pain points in vascular access, offering a safer, more comfortable alternative that appeals to hospitals aiming to improve patient experience and safety protocols, presenting a clear value proposition for healthcare providers seeking to modernize their blood collection practices.

Expanding Training Capabilities The launch of virtual training and implementation programs enhances onboarding and adoption, providing a scalable solution for hospital systems aiming to quickly integrate PIVO technology across multiple locations, thus encouraging broader utilization and increasing sales opportunities.